Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

1.410 +0.090 (+6.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cerus Corporation - Common Stock

< Previous 1 2 3 Next >
Cerus Corporation Celebrates World Blood Donor Day 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device
From Cerus Corporation
Via Business Wire
Cerus Corp. (NASDAQ: CERS) Making Surprising Moves in Wednesday Session
Via Investor Brand Network
Cerus Corporation Announces First Quarter 2025 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Third Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
From Cerus Corporation
Via Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2024
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces First Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS